Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 463169012 | Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 715639011 | Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler (substance) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1188992013 | Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler (product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 46638301000001119 | Fluticasone 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 77375501000001117 | Fluticasone propionate 100micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Is a | Salmeterol+fluticasone propionate | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has active ingredient | Substance with beta-2 adrenergic receptor agonist mechanism of action | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has active ingredient | Salmeterol | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has active ingredient | Fluticasone propionate | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has active ingredient | Corticosterone | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has active ingredient | Adrenal hormone agent | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Is a | Product containing fluticasone and salmeterol | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has active ingredient | Fluticasone | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has active ingredient | Fluticasone propionate | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has active ingredient | Corticosterone | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has active ingredient | Adrenal hormone agent | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has manufactured dose form | Inhalation dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has active ingredient | Salmeterol xinafoate | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has manufactured dose form | Breath activated powder inhaler | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has active ingredient | Salmeterol xinafoate | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has manufactured dose form | Inhalation powder | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has active ingredient | Fluticasone propionate | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has manufactured dose form | Conventional release powder for inhalation | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has manufactured dose form | Conventional release powder for inhalation | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Salmeterol | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has specific active ingredient | Salmeterol xinafoate | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has specific active ingredient | Fluticasone propionate | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has dispensed dose form | Conventional release powder for inhalation | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Is a | Virtual medicinal product | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has basis of strength substance | Salmeterol | false | Inferred relationship | Existential restriction modifier | ||
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler | Has manufactured dose form | Conventional release powder for inhalation | false | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets